Immunovant, Inc.
๋กฑ

IMVT Technical Analysis ๐Ÿง™

499
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes IMVT-1401 targets the neonatal Fc receptor (FcRn).

If you understand the idea,๐ŸŽฏ press a thumb up! ๐Ÿ‘ Have a question? Don't be shy to ask! ๐Ÿค“ Interested to study how to analyze charts, follow me!

๋ฉด์ฑ…์‚ฌํ•ญ

ํ•ด๋‹น ์ •๋ณด์™€ ๊ฒŒ์‹œ๋ฌผ์€ ๊ธˆ์œต, ํˆฌ์ž, ํŠธ๋ ˆ์ด๋”ฉ ๋˜๋Š” ๊ธฐํƒ€ ์œ ํ˜•์˜ ์กฐ์–ธ์ด๋‚˜ ๊ถŒ์žฅ ์‚ฌํ•ญ์œผ๋กœ ๊ฐ„์ฃผ๋˜์ง€ ์•Š์œผ๋ฉฐ, ํŠธ๋ ˆ์ด๋”ฉ๋ทฐ์—์„œ ์ œ๊ณตํ•˜๊ฑฐ๋‚˜ ๋ณด์ฆํ•˜๋Š” ๊ฒƒ์ด ์•„๋‹™๋‹ˆ๋‹ค. ์ž์„ธํ•œ ๋‚ด์šฉ์€ ์ด์šฉ ์•ฝ๊ด€์„ ์ฐธ์กฐํ•˜์„ธ์š”.